Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasm Metastasis × azeliragon × CNS × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Glioblastoma 4 Glioma 2 Neoplasms 1 Neoplasm Metastasis 1 Meningeal Carcinomatosis 1 Brain Neoplasms 1

Interventions

Radiosurgery 31 Radiotherapy 18 Temozolomide 14 Magnetic Resonance Spectroscopy 12 Surgical Procedures, Operative 6 Cyclophosphamide 5 trastuzumab deruxtecan 4 temsirolimus 4 Specimen Handling 4 motexafin gadolinium 3 fludarabine phosphate 3 aldesleukin 3 Pemetrexed 3 Mental Status and Dementia Tests 3 Fluorodeoxyglucose F18 3 Dexamethasone 3 fludarabine 2 entrectinib 2 efaproxiral 2 Trastuzumab 2 Topotecan 2 Sorafenib 2 Radiotherapy, Intensity-Modulated 2 Memantine 2 Mass Spectrometry 2 Laser Speckle Contrast Imaging 2 Irinotecan 2 Ipilimumab 2 Interleukin-2 2 Immunoenzyme Techniques 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05789589 2026-03-04

ADORATION

Baptist Health South Florida

Phase 1/2 Recruiting

Brain Neoplasms, Neoplasm Metastasis, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡